Skip to main content
Log in

Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione

  • Research Articles
  • Published:
Experientia Aims and scope Submit manuscript

Abstract

1,2,4-Triazolidine-3,5-diones and the 3,5-isoxazolidinedione were, observed to be, potent inhibitors of rat lens aldose reductase activity. In vivo in streptozotocin-diabetic rats, selected agents at 20 mg/kg/day, orally for 21 days reduced significantly the sorbitol levels of rbc, lens and sciatic nerves, suggesting that these derivatives may have some usefulness to treat clinical complications of diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Robison, W. G. R. Jr, Adv. exp. Med. Biol.246 (1988) 365.

    PubMed  Google Scholar 

  2. Kador, P. F., Med. res. Rev.8 (1988) 325.

    PubMed  Google Scholar 

  3. Notvest, R. R., and Inserra, J. J., Diabetes36 (1987) 500.

    PubMed  Google Scholar 

  4. Simard-Dequesne, N., Greseli, E., Dubuc, J., and Dvornik, D., Metabolism34 (1985) 885.

    PubMed  Google Scholar 

  5. Hansch, C., Sammes, P. G., and Taylor, J. B., Comp. med. Chem.2 (1990) 292.

    Google Scholar 

  6. Humber, L. G., Prog. med. Chem.24 (1987) 299.

    PubMed  Google Scholar 

  7. Lawson, E. R., Lipinski, C. A., and Sarges, R., Med. res. Rev.8 (1988) 159.

    PubMed  Google Scholar 

  8. Richon, A. B., Margoudakis, M. E., and Wasvary, J. S. J. med. Chem.25 (1982) 745.

    PubMed  Google Scholar 

  9. Izydore, R. A., Chapman, J. J., Mitchell, J. A., Cummings, R., Jones, G. T., and Mc Iver, C. D., J. Am. chem. Soc., Perkins TransII (1988) 1415.

    Google Scholar 

  10. Izydore, R. A., and McLean, S., J. chem. Soc.97 (1975) 5611.

    Google Scholar 

  11. Izydore, R. A., and Hall, I. H., U.S. Patent 4, 866,058 (1989).

  12. Izydore, R. A., Hall, I. H., and Simlot, R., Synthesis and Hypolipidemic Activity of 1,2,4-Triazolidine-3,5-diones. ACS Abstract (MEDI 45). Dallas, TX; April 10, 1989.

  13. Izydore, R. A., and Hall, I. H., U.S. Patent 4, 946,963 (1990).

  14. Izydore, R. A., and Hall, I. H., Hypolipidemic Activity of Isoxazolidine-3,5-diones. 3rd Chemical Congress of North America and the 195th ACS National Meeting (MEDI 126). Toronto, Canada, June 1988.

  15. Izydore, R. A., Bernal-Ramirez, J. A., Woodard, T., Okwisa, W. A., Daniels, D. L., Wong, O. T., and Hall, I. H., Eur. J. med. Chem. (1991) submitted.

  16. Hayman, S., and Kinoshita, J. H., J. biol. Chem.240 (1965) 877.

    PubMed  Google Scholar 

  17. Malone, J. I., Knox, G., Benford, S., and Tedesco, T. A., Diabetes29 (1980) 861.

    PubMed  Google Scholar 

  18. Simlot, R., Hall, I. H., and Izydore, R. A., Hypolipidemic Activity of Cyclic Hydazide Derivatives. 103rd N.C. Sectional Conference ACS. Chapel Hill, NC, April 15, 1989.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hall, I.H., Izydore, R.A., Simlot, R. et al. Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione. Experientia 48, 383–386 (1992). https://doi.org/10.1007/BF01923435

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01923435

Key words

Navigation